Convalescent Plasma Therapy Significantly improves the Clotting Kinetics of COVID-19 patients

Closed

Nina Nurarifah, Siti Fatonah, Herwindo Pudjo Brahmantyo, Shod Abdurrachman Dzulkarnain, Shinta Oktya Wardhani

2024 Research Journal of Pharmacy and Technology Vol. 17 Issue 4 Article Cited by 0 SDG 3SDG 17 Quartile

Abstract

Convalescent plasma therapy is approved as an effective therapy for severe or critical cases of COVID-19. However, there is concern regarding the impact of procoagulant factors in convalescent plasma. This study aims to prove the effect of convalescent plasma therapy on the coagulation status, especially the thromboelastography, of COVID-19 patients at Dr. Saiful Anwar Malang Hospital. This study used a survey method with a cross-sectional design between the group given convalescent plasma and the control group. Data taken from medical records. The independent variable is the convalescent plasma, while the dependent variable is the thromboelastography indicator (TEG); namely R time, K time, MA, and LY30. This study also compares the correlation between convalescent plasma therapy and patients’ comorbidities including hypertension, type 2 diabetes mellitus, and renal disease. Among 305 COVID-19 patients involved in this study, only 142 patients have completed medical record data for thromboelastography evaluation. Patient characteristics analysis shows a certain tendency in patients with comorbidities to receive convalescent plasma therapy. Although many indicators of thromboelastography did not have a significant correlation with convalescent plasma therapy, such as its R time and LY30, finally this study shows K time (which represents clotting kinetics) as the most significant indicator affected by convalescent plasma therapy. © RJPT All right reserved.

Affiliations

Division of Hematology and Oncology, Department of Internal Medicine of Dr. Saiful Anwar General Hospital, Faculty of Medicine, Universitas Brawijaya, East Java, Malang, 65145, Indonesia; Department of Clinical Pathology of Dr. Saiful Anwar General Hospital, Faculty of Medicine, Universitas Brawijaya, East Java, Malang, 65145, Indonesia; Department of Chemistry, Faculty of Mathematics and Natural Science, Universitas Negeri Surabaya, East Java, Surabaya, 60231, Indonesia

Research at a Glance

Premium content — register to unlock

Research at a Glance

Register to unlock

Topics & SDG Alignment

Premium content — register to unlock

Topics & SDG Alignment

Register to unlock

Collaboration

Premium content — register to unlock

Collaboration

Register to unlock

Author Profile (Selected)

Premium content — register to unlock

Author Profile (Selected)

Register to unlock

References Overview

Premium content — register to unlock

References Overview

Register to unlock

Journal & Source

Premium content — register to unlock

Journal & Source

Register to unlock

Metadata & Integrity

Premium content — register to unlock

Metadata & Integrity

Register to unlock